Nanox Imaging Ltd. (NASDAQ: NNOX), a company focused on transforming medical imaging through its integrated platform, has announced it will release its financial results for the second quarter of 2026 before the market opens on September 9, 2026. The announcement, made via a press release, also revealed that CEO and Acting Chairman Erez Meltzer and CFO Guy Nathanzon will host a conference call at 8:30 a.m. ET that day to discuss the results and provide a business update. A live webcast will be accessible through the Investor Relations section of the Nanox website.
This upcoming report comes at a critical time for Nanox as it continues to advance its mission of driving the world’s transition to preventive healthcare. The company’s platform is designed to integrate affordable imaging hardware, AI-based solutions, cloud-based software, remote radiology access, health IT solutions, and a marketplace. By combining these elements, Nanox aims to enable earlier detection of diseases, improve clinical efficiency, and broaden access to care, both within and beyond traditional hospital settings.
Key components of the Nanox ecosystem include the Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI algorithms that help identify early signs of chronic disease in routine CT imaging; Nanox.CLOUD, a secure cloud platform for data management and advanced imaging analytics; and Nanox.MARKETPLACE, along with USARAD Holdings, which provides access to remote radiology and cardiology experts. Additionally, Nanox Health IT offers RIS, PACS, AI, dictation, and secure infrastructure solutions designed to streamline workflows and enhance care delivery.
The company’s strategy focuses on lowering barriers to adoption and improving utilization of medical imaging, with the ultimate goal of advancing preventive care worldwide. Investors and industry observers will be keen to see how Nanox’s financial performance in the second quarter reflects progress toward these goals, as well as any updates on commercialization efforts, partnerships, or technological developments.
The conference call and webcast will provide an opportunity for stakeholders to hear directly from management about the company’s performance and future outlook. The full press release with details on the call can be accessed at https://ibn.fm/y877D. As Nanox continues to innovate in the medical imaging space, its quarterly results offer a window into the adoption and impact of its technologies.
Nanox’s commitment to expanding the reach of medical imaging is underscored by its proprietary digital X-ray technology and AI-driven analytics, which are intended to enhance routine imaging workflows and support early disease detection. The upcoming financial report will be a key indicator of the company’s trajectory and its ability to execute on its vision of a seamless solution from scan to interpretation and beyond.
